Clara Young

Clara Young

Auto-generated profile, based on publicly available information

Clara Young

Garvan Institute of Medical Research, Darlinghurst, NSW, Australia; St Vincent's Clinical School, UNSW Sydney, Sydney, NSW, Australia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Immunity
Verified
Journal Article
Closed access
CSChristopher Sundling
Christopher Sundling
ALAngelica W.Y. Lau
Angelica W.Y. Lau
KBKatherine Bourne
Katherine Bourne
CYClara Young
Clara Young
CLCandy Laurianto
Candy Laurianto
RBRobert Brink
Robert Brink

10 November 2016 in Nature Communications
Verified
Journal Article
Open access
ZSZahra Sabouri
Zahra Sabouri
SPSamuel Perotti
Samuel Perotti
ESEmily Spierings
Emily Spierings
PHPeter Humburg
Peter Humburg
MYMehmet Yabas
Mehmet Yabas
CGChristopher C. Goodnow
Christopher C. Goodnow
Self-tolerance by clonal anergy of B cells is marked by an increase in IgD and decrease in IgM antigen receptor surface expression, yet the function of IgD on anergic cells is obscure. Here we define the RNA landscape of thein vivoanergy response, comprising 220 induced sequences including a core set of 97. Failure to co-express IgD with IgM decreases overall expression of receptors for self-antigen, but paradoxically increases the core anergy response, exemplified by increasedSdc1encoding the cell surface marker syndecan-1. IgD expressed on its own is nevertheless competent to induce calcium signalling and the core anergy mRNA response. Syndecan-1 induction correlates with reduction of surface IgM and is exaggerated without surface IgD in many transitional and mature B cells. These results show that IgD attenuates the response to self-antigen in anergic cells and promotes their accumulation. In this way, IgD minimizes tolerance-induced holes in the pre-immune antibody repertoire.

15 January 2025 in Immunity
Verified
Journal Article
Open access
CYClara Young
Clara Young
MSMandeep Singh
Mandeep Singh
KJKatherine J.L. Jackson
Katherine J.L. Jackson
MFMatthew Field
Matthew Field
TPTimothy J. Peters
Timothy J. Peters
CGChristopher C. Goodnow
Christopher C. Goodnow
The unexplained association between infection and autoimmune disease is strongest for hepatitis C virus-induced cryoglobulinemic vasculitis (HCV-cryovas). To analyze its origins, we traced the evolution of pathogenic rheumatoid factor (RF) autoantibodies in four HCV-cryovas patients by deep single-cell multi-omic analysis, revealing three sources of B cell somatic mutation converged to drive the accumulation of a large disease-causing clone. A method for quantifying low-affinity binding revealed recurring antibody variable domain combinations created by V(D)J recombination that bound self-immunoglobulin G (IgG) but not viral E2 antigen. Whole-genome sequencing revealed thousands of somatic mutations, numerically comparable to chronic lymphocytic leukemia and normal memory B cells, but with 1-2 corresponding to driver mutations found recurrently in B cell leukemia and lymphoma. V(D)J hypermutation created autoantibodies with compromised solubility in complex with self-IgG. In this virus-induced autoimmune disease, infection promotes a catastrophic confluence of somatic mutagenesis in the descendants of a single B cell.